Aesculap acquired Dextera Surgical, expanding its portfolio of beating heart coronary and video-assisted thoracic surgery solutions, according to The Morning Call. Here are four insights:
1. Aesculap submitted a $17.3 million "stalking-horse bid" for Dextera Surgical after the company filed for voluntary Chapter 11 bankruptcy protection in December 2017.
2. Although potential buyers were permitted to submit higher bids in the court-supervised auction, no other entity submitted a bid by the deadline.
3. Aesculap will continue manufacturing and distributing Dextera Surgical's products, taking over operations in Redwood City.
4. Dextera Surgical designs, manufactures and markets medical devices, including surgical staplers and devices for coronary artery bypass graft surgery.